Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BeiGene, Ltd. stock logo
BGNE
BeiGene
$153.66
+3.4%
$154.73
$126.97
$266.67
$14.70B0.61256,387 shs52,042 shs
Centene Co. stock logo
CNC
Centene
$72.03
-4.8%
$76.42
$60.83
$81.42
$38.53B0.383.04 million shs1.99 million shs
Humana Inc. stock logo
HUM
Humana
$308.20
-1.0%
$328.56
$299.23
$541.21
$37.18B0.451.98 million shs214,138 shs
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
$342.59
-2.8%
$391.53
$266.35
$423.92
$20.07B0.47398,290 shs137,943 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BeiGene, Ltd. stock logo
BGNE
BeiGene
+3.08%+12.58%-3.41%-8.24%-39.62%
Centene Co. stock logo
CNC
Centene
-0.68%+2.61%-2.43%+2.58%+13.57%
Humana Inc. stock logo
HUM
Humana
-1.47%-4.13%-10.61%-13.79%-38.39%
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
-4.17%-2.37%-15.79%-0.37%+27.84%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BeiGene, Ltd. stock logo
BGNE
BeiGene
2.8176 of 5 stars
4.42.00.00.01.91.70.6
Centene Co. stock logo
CNC
Centene
4.7902 of 5 stars
2.35.00.03.93.72.53.1
Humana Inc. stock logo
HUM
Humana
4.9984 of 5 stars
4.23.03.33.93.03.33.1
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
4.9653 of 5 stars
3.25.00.04.62.62.53.8

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BeiGene, Ltd. stock logo
BGNE
BeiGene
2.80
Moderate Buy$250.1362.78% Upside
Centene Co. stock logo
CNC
Centene
2.55
Moderate Buy$85.2518.35% Upside
Humana Inc. stock logo
HUM
Humana
2.47
Hold$433.7440.73% Upside
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
2.33
Hold$396.0915.62% Upside

Current Analyst Ratings

Latest MOH, CNC, HUM, and BGNE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Humana Inc. stock logo
HUM
Humana
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$415.00 ➝ $353.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$391.00 ➝ $360.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$334.00 ➝ $326.00
4/25/2024
Humana Inc. stock logo
HUM
Humana
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$415.00 ➝ $370.00
4/25/2024
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$437.00 ➝ $430.00
4/25/2024
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$390.00
4/24/2024
BeiGene, Ltd. stock logo
BGNE
BeiGene
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$235.00 ➝ $236.00
4/22/2024
Humana Inc. stock logo
HUM
Humana
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$411.00 ➝ $381.00
4/15/2024
Centene Co. stock logo
CNC
Centene
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$89.00 ➝ $93.00
4/15/2024
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$440.00 ➝ $410.00
4/10/2024
Humana Inc. stock logo
HUM
Humana
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$391.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BeiGene, Ltd. stock logo
BGNE
BeiGene
$2.46B5.98N/AN/A$37.10 per share4.14
Centene Co. stock logo
CNC
Centene
$154.00B0.25$8.74 per share8.24$48.55 per share1.48
Humana Inc. stock logo
HUM
Humana
$106.37B0.35$33.43 per share9.22$134.15 per share2.30
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
$34.07B0.59$22.13 per share15.48$72.30 per share4.74

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BeiGene, Ltd. stock logo
BGNE
BeiGene
-$881.71M-$8.50N/AN/AN/A-35.86%-23.12%-15.32%5/2/2024 (Estimated)
Centene Co. stock logo
CNC
Centene
$2.70B$4.9114.679.530.951.75%14.26%4.36%4/26/2024 (Confirmed)
Humana Inc. stock logo
HUM
Humana
$2.49B$16.0619.1913.831.851.82%17.76%5.63%8/7/2024 (Estimated)
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
$1.09B$18.4318.5912.601.032.99%30.99%8.36%7/24/2024 (Estimated)

Latest MOH, CNC, HUM, and BGNE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/26/2024Q1 24
Centene Co. stock logo
CNC
Centene
$2.20$2.26+$0.06N/A$36.43 billion$40.41 billion  
4/24/2024Q1 24
Humana Inc. stock logo
HUM
Humana
$6.12$7.23+$1.11$8.35$28.52 billion$29.61 billion      
4/24/2024Q1 2024
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
$5.46$5.73+$0.27$6.29$9.45 billion$9.93 billion      
2/26/202412/31/2023
BeiGene, Ltd. stock logo
BGNE
BeiGene
-$3.61-$3.53+$0.08-$3.53$632.52 million$634.40 million
2/7/2024Q4 2023
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
$4.31$4.38+$0.07$5.06$8.35 billion$9.05 billion    
2/6/202412/31/2023
Centene Co. stock logo
CNC
Centene
$0.43$0.45+$0.02$0.82$36.16 billion$39.46 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BeiGene, Ltd. stock logo
BGNE
BeiGene
N/AN/AN/AN/AN/A
Centene Co. stock logo
CNC
Centene
N/AN/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
$3.541.15%+12.29%22.04%7 Years
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
N/AN/AN/AN/AN/A

Latest MOH, CNC, HUM, and BGNE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/18/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88501.09%6/28/20246/28/20247/26/2024
2/15/2024
Humana Inc. stock logo
HUM
Humana
quarterly$0.88500.97%3/27/20243/29/20244/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BeiGene, Ltd. stock logo
BGNE
BeiGene
0.06
2.32
2.09
Centene Co. stock logo
CNC
Centene
0.68
1.11
1.11
Humana Inc. stock logo
HUM
Humana
0.77
1.67
1.59
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
0.57
1.54
1.54

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BeiGene, Ltd. stock logo
BGNE
BeiGene
48.55%
Centene Co. stock logo
CNC
Centene
93.63%
Humana Inc. stock logo
HUM
Humana
92.38%
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
98.50%

Insider Ownership

CompanyInsider Ownership
BeiGene, Ltd. stock logo
BGNE
BeiGene
7.40%
Centene Co. stock logo
CNC
Centene
0.33%
Humana Inc. stock logo
HUM
Humana
0.32%
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
1.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BeiGene, Ltd. stock logo
BGNE
BeiGene
10,60095.64 million88.56 millionOptionable
Centene Co. stock logo
CNC
Centene
67,700534.91 million533.14 millionOptionable
Humana Inc. stock logo
HUM
Humana
67,600120.65 million120.27 millionOptionable
Molina Healthcare, Inc. stock logo
MOH
Molina Healthcare
123,12358.58 million57.94 millionOptionable

MOH, CNC, HUM, and BGNE Headlines

SourceHeadline
Molina Healthcare First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMolina Healthcare First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
finance.yahoo.com - April 26 at 9:52 AM
Handelsbanken Fonder AB Has $4.24 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)Handelsbanken Fonder AB Has $4.24 Million Holdings in Molina Healthcare, Inc. (NYSE:MOH)
marketbeat.com - April 26 at 6:39 AM
Molina to challenge Medicaid contract losses in Florida, VirginiaMolina to challenge Medicaid contract losses in Florida, Virginia
healthcaredive.com - April 26 at 4:50 AM
Molina Healthcares Moms Club teams up with You Eat, I Eat for health and savings eventMolina Healthcare's Mom's Club teams up with You Eat, I Eat for health and savings event
msn.com - April 26 at 4:50 AM
Molina Healthcare Inc (MOH) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and ...Molina Healthcare Inc (MOH) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and ...
finance.yahoo.com - April 26 at 4:50 AM
Decoding Molina Healthcare Inc (MOH): A Strategic SWOT InsightDecoding Molina Healthcare Inc (MOH): A Strategic SWOT Insight
finance.yahoo.com - April 26 at 4:50 AM
Molina Healthcare Inc (MOH) Investor Alert: Key Takeaways From Their Latest SEC 10-Q FilingMolina Healthcare Inc (MOH) Investor Alert: Key Takeaways From Their Latest SEC 10-Q Filing
americanbankingnews.com - April 26 at 4:06 AM
Molina Healthcare Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)Molina Healthcare Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
markets.businessinsider.com - April 25 at 6:50 PM
Molina Healthcare (MOH) Q1 Earnings Beat on Growing MembershipMolina Healthcare (MOH) Q1 Earnings Beat on Growing Membership
zacks.com - April 25 at 3:31 PM
Molina Healthcare (NYSE:MOH) Price Target Lowered to $430.00 at BarclaysMolina Healthcare (NYSE:MOH) Price Target Lowered to $430.00 at Barclays
marketbeat.com - April 25 at 3:29 PM
Molina Healthcare: Revenue Upside Clashes with MLR Concerns, Justifying Underperform RatingMolina Healthcare: Revenue Upside Clashes with MLR Concerns, Justifying Underperform Rating
markets.businessinsider.com - April 25 at 1:47 PM
Truist Financial Keeps Their Buy Rating on Molina Healthcare (MOH)Truist Financial Keeps Their Buy Rating on Molina Healthcare (MOH)
markets.businessinsider.com - April 25 at 1:47 PM
Molina Healthcare (NYSE:MOH) Given Equal Weight Rating at StephensMolina Healthcare (NYSE:MOH) Given Equal Weight Rating at Stephens
marketbeat.com - April 25 at 1:38 PM
Molina Healthcare (NYSE:MOH) Issues Quarterly  Earnings Results, Beats Expectations By $0.27 EPSMolina Healthcare (NYSE:MOH) Issues Quarterly Earnings Results, Beats Expectations By $0.27 EPS
marketbeat.com - April 25 at 10:44 AM
Molina Healthcare Posts Drop in 1Q ProfitMolina Healthcare Posts Drop in 1Q Profit
marketwatch.com - April 24 at 9:02 PM
Molina: Q1 Earnings SnapshotMolina: Q1 Earnings Snapshot
washingtonpost.com - April 24 at 9:02 PM
MOH Stock Earnings: Molina Healthcare Beats EPS, Beats Revenue for Q1 2024MOH Stock Earnings: Molina Healthcare Beats EPS, Beats Revenue for Q1 2024
markets.businessinsider.com - April 24 at 9:02 PM
Molina (MOH) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesMolina (MOH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com - April 24 at 7:01 PM
Molina Healthcare (NYSE:MOH) Updates FY 2024 Earnings GuidanceMolina Healthcare (NYSE:MOH) Updates FY 2024 Earnings Guidance
marketbeat.com - April 24 at 6:49 PM
Molina Healthcare beats profit estimates aided by higher premiumsMolina Healthcare beats profit estimates aided by higher premiums
reuters.com - April 24 at 6:03 PM
Molina Healthcare Reports First Quarter 2024 Financial ResultsMolina Healthcare Reports First Quarter 2024 Financial Results
businesswire.com - April 24 at 4:15 PM
Molina Healthcare of Texas hosts Budgeting Workshop as part of Molina’s Grandparents Social ClubMolina Healthcare of Texas hosts Budgeting Workshop as part of Molina’s Grandparents Social Club
kvia.com - April 24 at 4:01 PM
Molina Healthcare IncMolina Healthcare Inc
money.usnews.com - April 24 at 4:01 PM
Molina Healthcare, Inc. (NYSE:MOH) Stock Holdings Lifted by Demars Financial Group LLCMolina Healthcare, Inc. (NYSE:MOH) Stock Holdings Lifted by Demars Financial Group LLC
marketbeat.com - April 24 at 9:39 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

BeiGene logo

BeiGene

NASDAQ:BGNE
BeiGene, Ltd., through its subsidiaries, engages in the development and commercialization of oncology medicines worldwide. Its products include BRUKINSA to treat various blood cancers; TEVIMBRA to treat various solid tumor and blood cancers; PARTRUVIX for the treatment of various solid tumor malignancies; XGEVA to treat bone metastases from solid tumors and multiple myeloma, as well as giant cell tumor of bone; BLINCYTO to treat acute lymphoblastic leukemia; KYPROLIS to treat R/R multiple myeloma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; SYLVANT to treat idiopathic multicentric castleman disease; QARZIBA to treat neuroblastoma; POBEVCY to treat metastatic colorectal cancer, liver cancer, and non-small cell lung cancer (NSCLC); BAITUOWEI, to treat breast and prostate cancers; TAFINLAR and MEKINIST to treat NSCLC and melanoma; VOTRIENT for advance renal cell carcinoma; AFINITOR for advance renal cell carcinoma, NET, SEGA, & breast cancers; and ZYKADIA to treat ALK + NSCLC. The company is also developing inhibitors comprising Sonrotoclax (BGB-11417), BGB-10188, BGB-21447, Ociperlimab (BGB-A1217), Surzebiclimab (BGB-A425), BGB-15025, BGB-26808, Lifirafenib (BGB-283), BGB-3245, BGB-30813, and BGB-43395; antibodies, including Zanidatamab, BGB-A445, and BGB-A3055, as well as BGB-16673, a BTK-targeted CDAC, and BGB-24714, a SMAC mimetic. It has collaborations with Shoreline Biosciences, Inc., Amgen Inc., Novartis AG, Bristol Myers Squibb company, Shandong Luye Pharmaceutical Co., Ltd., Nanjing Leads Biolabs, Inc., EUSA Pharma, Assembly Biosciences, Inc., Bio-Thera Solutions, Ltd., and Nanjing Leads Biolabs Co., Ltd. The company was incorporated in 2010 and is based in Grand Cayman, the Cayman Islands.
Centene logo

Centene

NYSE:CNC
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Humana logo

Humana

NYSE:HUM
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Molina Healthcare logo

Molina Healthcare

NYSE:MOH
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.